Complete Access to New Interviews, the Archive, and all Special Reports.

Patrick NJ Schnegelsberg is the CEO of Picard Medical Inc. and its wholly owned subsidiary SynCardia Systems LLC. Mr. Schnegelsberg has over 25 years of executive leadership experience and a proven ...

David Nierengarten, Ph.D., is Managing Director, Equity Research at Wedbush Securities. He has been a senior analyst covering small-mid cap biotech stocks with a heavy focus on oncology, rare disease ...

Mitchel Penn, CFA, is Managing Director and Senior Analyst covering business development companies for Oppenheimer & Co. Inc. Prior to joining Oppenheimer, he followed business development companies ...

Eric K. Olson is President, Chief Executive Officer and Chairman of the Board of SINTX Technologies Inc. He has been a serial founder and entrepreneur in a broad range of medical device, diagnostic, ...

Sean-Paul Adams is a Senior Research Analyst at B. Riley Securities covering business development companies (BDCs) and the broader specialty finance sector. Prior to joining B. Riley Securities, he ...

Matt Phipps, Ph.D., is Group Head of Biotechnology Equity Research at William Blair & Co, LLC. He joined the firm in November 2014, after working as a postdoctoral research fellow at Texas Scottish ...

John C. Rood is Chief Executive Officer and Chairman of Momentus Inc., a U.S. commercial space company that offers in-space infrastructure services, including in-space transportation, hosted payloads ...

Hessam Nadji joined Marcus & Millichap in 1996 as Vice President of research and advisory services and has served as the company’s President and Chief Executive Officer since 2016. During those years, ...

Andrew Wells serves as Chief Investment Officer of SanJac Alpha LP and is responsible for oversight of the adviser’s fund activities. From 2015-2023 Mr. Wells was Chief Investment Officer of Saracen ...

Joseph M. DeVivo is President, Chief Executive Officer, and Chairman of the Board of Butterfly Network, Inc., a digital health company developing portable, semiconductor-based ultrasound devices and ...

Oren Hershkovitz, Ph.D., has been serving as CEO of Enlivex Therapeutics Ltd. since 2019. He is a seasoned biotech executive with over 15 years of experience in strategic and operational roles, ...